Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neurosci Res ; 86(15): 3359-74, 2008 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-18627035

RESUMO

An infecting strain VLA2/18 of Campylobacter jejuni was obtained from an individual with campylobacteriosis and used to prepare chicken sera by experimental infection to investigate the role of serum anti-ganglioside antibodies in Guillain-Barré syndrome. Both sera of the patient and chicken contained anti-ganglioside antibodies and anti-Lipid A (anti-Kdo2-Lipid A) antibodies directed against the lipid A portion of the bacterial lipooligosaccharide. The anti-Kdo2-Lipid A activities inhibited voltage-gated Na (Nav) channel of NSC-34 cells in culture. We hypothesized that anti-Kdo2-Lipid A antibody acts on the functional inhibition of Nav1.4. To test this possibility, a rabbit peptide antibody (anti-Nav1.4 pAb) against a 19-mer peptide (KELKDNHILNHVGLTDGPR) on the alpha subunit of Nav1.4 was produced. Anti-Nav1.4 pAb was cross-reactive to Kdo2-Lipid A. Anti-Kdo2-lipid A antibody activity in the chicken serum was tested for the Na(+) current inhibition in NSC-34 cells in combination with mu-Conotoxin and tetrodotoxin. Contrary to our expectations, the anti-Kdo2-Lipid A antibody activity was extended to Nav channels other than Nav1.4. By overlapping structural analysis, it was found that there might be multiple peptide epitopes containing certain dipeptides showing a structural similarity with v-Lipid A. Thus, our study suggests the possibility that there are multiple epitopic peptides on the extracellular domains of Nav1.1 to 1.9, and some of them may represent target sites for anti-Kdo2-Lipid A antibody, to induce neurophysiological changes in GBS by disrupting the normal function of the Nav channels.


Assuntos
Autoanticorpos/imunologia , Autoantígenos/imunologia , Infecções por Campylobacter/imunologia , Campylobacter jejuni/imunologia , Lipídeo A/imunologia , Canais de Sódio/imunologia , Sequência de Aminoácidos , Animais , Especificidade de Anticorpos , Western Blotting , Galinhas , Reações Cruzadas , Ensaio de Imunoadsorção Enzimática , Epitopos de Linfócito B/imunologia , Gangliosídeos/imunologia , Humanos , Imuno-Histoquímica , Camundongos , Dados de Sequência Molecular , Técnicas de Patch-Clamp , Peptídeos/imunologia , Isoformas de Proteínas/imunologia , Canais de Sódio/química
2.
Biol Pharm Bull ; 30(11): 2027-30, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17978470

RESUMO

Human parvovirus B19 is a clinically important pathogen in both children and adults. In adults, it frequently causes acute and chronic arthritis, which may be related to persistent infection. The effect of the capsid of human parvovirus B19 on monocytes, which are thought to be responsible for the first line of defense against parvoviral infection, is not well understood. In this study, we investigated changes in mRNA expression levels of several immunoregulatory cytokines in monocytic cells after treatment with the B19 capsid. When human monocytic cell line THP-1 cells were treated with the B19 capsid, the expression of tumor necrosis factor alpha (TNF-alpha) mRNA was suppressed independently of transforming growth factor beta (TGF-beta) mRNA. In contrast, the level of mRNA for interleukin-1 alpha (IL-1alpha) remained unchanged, and that for interleukin-1 beta (IL-1beta) was slightly increased after the capsid treatment. Flow cytometry demonstrated that THP-1 cells treated with B19 capsid showed no differences in surface expression of CD11a, CD16 and CD33, as compared with control cells. These findings that B19 capsid antigen did not promote positive responses for production of TNF-alpha and IL-1alpha may provide insight into the mechanisms of persistent infection of human parvovirus B19 and the systemic viral spread via bloodstream.


Assuntos
Proteínas do Capsídeo/farmacologia , Citocinas/metabolismo , Monócitos/efeitos dos fármacos , Parvovirus B19 Humano/imunologia , Linhagem Celular , Citocinas/genética , Citometria de Fluxo , Humanos , Técnicas In Vitro , Interleucina-1alfa/metabolismo , Interleucina-1beta/metabolismo , Lipopolissacarídeos/farmacologia , Monócitos/metabolismo , RNA Mensageiro/metabolismo , Fator de Necrose Tumoral alfa/antagonistas & inibidores
3.
Neurochem Res ; 31(5): 589-96, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16770729

RESUMO

Voltage-gated K(+) channels contain six membrane spanning segments and a pore-forming domain. We used site-directed mutation to examine the role of specific amino acids in the extracellular region of the pore in Kv1.2. When expressed in CHO cells, a K(+) current was not observed for mutants S356A, S360A, T383A and T384A. However, coexpression of the Kvbeta2 subunit and the S360A mutant resulted in a robust peak current. Immunocytochemistry for Kv1.2 showed staining throughout the cytoplasm in cells coexpressing the beta2 and S360A, whereas only the perinuclear region was stained in cells expressing the S360A mutant. Western blotting revealed that the major immunoreactive protein in wild-type- and mutant-expressing cells is 60-kDa, but 87-kDa bands were also detected in cells expressing wild-type Kv1.2 and cells coexpressing beta2and S360A. These results suggest that amino acids in the pore region help regulate ion permeability or cellular trafficking by affecting glycosylation of Kv1.2.


Assuntos
Canal de Potássio Kv1.2/química , Canal de Potássio Kv1.2/metabolismo , Estrutura Terciária de Proteína , Sequência de Aminoácidos , Animais , Protocolos de Quimioterapia Combinada Antineoplásica , Células , Cricetinae , Cricetulus , Ciclofosfamida , Doxorrubicina , Glicosilação , Canal de Potássio Kv1.2/genética , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Técnicas de Patch-Clamp , Potássio/metabolismo , Subunidades Proteicas/química , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Ratos , Vincristina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...